SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is sharply lower after its mixed quarterly report showed strong revenue growth and user acquisition but also a net loss driven by increased credit loss provisions and a cautious near-term forecast. The community is debating the long-term viability of the buy now, pay later model amidst concerns over credit risk and the company's path to profitability.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL Inc. is trending due to a steep stock decline after its Galleri cancer test missed a primary statistical endpoint in a UK trial. This has sparked a divided community discussion, with some viewing the sell-off as an overreaction given positive underlying detection data and strong financials, while others emphasize the trial's miss and broader biotech sector risks.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

IMG CRYPTO is trending as its dedicated community celebrates its 1-year anniversary, rallying around its unique "infinite money glitch" model that automatically rewards holders with Solana and continues to roll out new features and liquidity pools.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community eagerly anticipates the imminent resubmission of its Biologics License Application for Deramiocel, a Duchenne muscular dystrophy treatment, driving optimism for a significant short squeeze. Investors are closely watching for updates on the company's StealthX vaccine platform and broader FDA regulatory consistency, viewing CAPR as a promising, undervalued biotech in the rare disease space.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending due to its transformative all-stock merger with Valaris, creating a dominant offshore drilling powerhouse with an expanded fleet and substantial backlog. Community discussion, despite initial earnings reports, is focused on the adjusted positive performance, significant debt reduction efforts, and the strategic advantages of the acquisition in a resurgent energy market, with many anticipating a short squeeze.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending amid reactions to a new public stock offering and a contingent royalty funding agreement, fueling community debate about significant shareholder dilution versus securing critical capital for its lead prostate cancer candidate's potential commercialization and to strengthen its financial runway.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic (LUNC) is trending amid intense community debate following the Do Kwon sentencing, with proponents anticipating a resurgence fueled by ongoing Binance burns and new ecosystem initiatives, contrasting with persistent skepticism about its long-term viability.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending following a mixed reaction to its recent earnings and 2026 outlook; while Q4 delivered strong results and record cash flow, weaker production guidance and higher costs for the upcoming year have triggered a sell-off. This has sparked community debate on whether the downturn is an overreaction or a strategic entry point, particularly as many believe gold prices will remain elevated.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid intensified buyout speculation from major tech players like SpaceX or Amazon, following reports of Apple potentially integrating Starlink, a move that highlights the critical value of GSAT's globally harmonized Band n53 spectrum and established Apple partnership. The community eagerly awaits key FCC rulings on spectrum use and C-3 constellation approval, viewing these as pivotal catalysts for its future in direct-to-device and private 5G networks for IoT and drones.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences (VTYX) is trending amid intense speculation that Eli Lilly's $14 per share acquisition offer dramatically undervalues the company, prompting widespread anticipation of a bidding war from other major pharmaceutical players. Investors are actively discussing the potential for significantly higher bids, citing VTYX's promising NLRP3 inhibitor pipeline for cardiometabolic and neuroinflammatory diseases and drawing comparisons to recent aggressive biotech M&A.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

UBX
Unity Biotechnology Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UBX News

UBXUnity Biotechnology Inc